EUVIMEDEUVIMED entdecken
Crossref

Characterizing Adverse Effects and Risk Factors in Multidrug Tuberculosis Regimens: Implications for Personalized Treatment Protocols

Nagababu Kandula

Journal of Artificial intelligence and Machine Learning · 2023 · 1 (2) · 1-8

DOI: 10.55124/jaim.v1i2.291 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Artificial intelligence and Machine Learning, 2023. Verfasst von Nagababu Kandula. Die Arbeit wurde bisher 1-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tuberculosis treatment requires complex multidrug regimens that present significant challenges, including drug-induced hepatotoxicity, pharmacokinetic interactions, and complications in HIV co-infection. Rifampin’s potent enzyme induction and adverse effect profiles, particularly in drug-resistant cases, necessitate a comprehensive understanding of drug-drug interactions. This study addresses important knowledge gaps in tuberculosis treatment by identifying predictors of individual patient responses, characterizing interactions with high-dose rifampicin, and developing evidence-based strategies to optimize treatment protocols while minimizing adverse effects. Data were systematically collected from 459 participants across multiple healthcare facilities, analyzing demographics, treatment regimens, and adverse effects through standardized forms and hospital management systems. The analysis revealed that age significantly influences treatment complications, with insomnia (62%), vomiting (61%) and neuropathy (60%) being the most prevalent. Dose levels were significantly associated with rifampicin, cycloserine and ethambutol use, while geographical location did not show significant associations. The findings underscore the need for personalized treatmen protocols that consider age-related differences and optimal dosing strategies to improve adherence and outcomes in tuberculosis management. Keywords: Tuberculosis Treatment, Drug-Drug Interactions, Adverse Drug Reactions, Rifampicin, Pharmacokinetics Interactions, Multidrug-Resistant Tuberculosis, HIV-Tuberculosis Co-infection

Zitieren

APA

Kandula, N. (2023). Characterizing Adverse Effects and Risk Factors in Multidrug Tuberculosis Regimens: Implications for Personalized Treatment Protocols. Journal of Artificial intelligence and Machine Learning, 1(2), 1-8. https://doi.org/10.55124/jaim.v1i2.291

Vancouver

Kandula N. Characterizing Adverse Effects and Risk Factors in Multidrug Tuberculosis Regimens: Implications for Personalized Treatment Protocols. Journal of Artificial intelligence and Machine Learning. 2023;1(2):1-8. doi:10.55124/jaim.v1i2.291

BibTeX
@article{Kandula2023,
  author = {Kandula, Nagababu},
  title = {Characterizing Adverse Effects and Risk Factors in Multidrug Tuberculosis Regimens: Implications for Personalized Treatment Protocols},
  journal = {Journal of Artificial intelligence and Machine Learning},
  year = {2023},
  volume = {1},
  number = {2},
  pages = {1--8},
  doi = {10.55124/jaim.v1i2.291}
}
Kostenlos starten →